People · Operator
Named in public records as an officer, director or promoter · active 2018–2018 · Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| NICO Corp | — | Other Health Care | Series B | $58.7M | $143.0M | 2018 |
Dr. Mark L. Rosenblum at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Dr. Mark L. Rosenblum on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Carter McNabb | 1 | 10 |
| Niles L. Noblitt | 1 | 3 |
| Keith E. Brauer | 1 | 2 |
| J. Carter McNabb | 1 | 2 |
| Joseph L. Mark | 1 | 2 |
| Jeffrey L. Hanthorn | 1 | 2 |
| MARK ROSENBLUM | 1 | 2 |
| Joseph Mark | 1 | 1 |
| Joe Mark | 1 | 1 |
| Thomas L. Tefft | 1 | 1 |
| Eric L. Timko | 1 | 1 |
| Jeffrey Hanthorn | 1 | 1 |
| Jim Pearson | 1 | 1 |
| James R. Baumgardt | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.